Abstract：
COVID-19 is an infectious disease caused by SARS-CoV-2 that is characterized by respiratory symptoms, fever, and chills.[1] While these systemic symptoms are widely known and well understood, there have also been reports of dermatological manifestations in patients with COVID-19. These manifestations include chilblain-like lesions, maculopapular lesions, urticarial lesions, necrosis, and other varicella-like exanthems.[2] The pathogenesis of these lesions are not well understood, but the procoagulant and pro-inflammatory state induced by COVID-19 infections may be contributing to varied cutaneous manifestations.[3] Drug interactions and concurrent hypersensitivity reactions have also been postulated.[4] This review aims to compile and analyze various retrospective studies and case reports to summarize the clinical presentation of dermatological lesions associated with COVID-19 infections and suggest further areas of research.
摘要：
COVID-19是由SARS-CoV-2引起的以呼吸道症状为特征的传染病，发烧,和寒战。[1]虽然这些全身性症状是众所周知和众所周知的，也有COVID-19患者的皮肤病学表现的报道。这些表现包括冻疮样病变，斑丘疹病变,荨麻疹病变,坏死,和其他类似水痘的激词.[2]这些病变的发病机制尚不清楚，但COVID-19感染诱导的促凝和促炎状态可能导致各种皮肤表现.[3]药物相互作用和并发的超敏反应也被假定。[4]这篇综述旨在汇编和分析各种回顾性研究和病例报告，以总结与COVID-19感染相关的皮肤病学病变的临床表现，并提出进一步的研究领域。
